Date: October 13, 2026
Regulatory Compliance Response
Brooks Laboratories Limited has responded to a letter from the National Stock Exchange of India Ltd dated October 12, 2026 (Ref No.: NSE/CM/Surveillance/17685) regarding "Movement in Price".
The company states that it has disclosed all material information having a bearing on the operations/performance of the company to the stock exchange within stipulated timeframes. This includes all necessary disclosures in accordance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Price Movement Clarification
The company explicitly states that it is "not aware of the reason for the significant changes in our share price." Management attributes the movement in share price and volumes as "purely market driven" and asserts that "the management of the Company is in no way connected with the changes in the share prices."
Compliance Reaffirmation
The company reiterates its commitment to regulatory compliance, stating: "The Company has always and will continue to adhere to the compliances required under the Listing Regulations and other applicable laws."